EUVIMEDOpdag EUVIMED
Crossref

Copolymer liquid embolization of dural arteriovenous fistulas: A 20‐year single‐center experience

Richard Voldřich iD, František Charvát, David Netuka

Journal of Neuroimaging · 2023-11 · 33 (6) · 926-932

DOI: 10.1111/jon.13148 ↗

At a glance

Journal article in Journal of Neuroimaging, published online on 2023-08-21. Written by Richard Voldřich and 2 co-authors. Institution: Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Military University Hospital, Prague, Czech Republ…. Major MEDLINE topics: Central Nervous System Vascular Malformations, Embolization, Therapeutic, Fistula. Cited 5 times so far (Crossref); 30 references. Funded by: Agentura Pro Zdravotnický Výzkum České Republiky, Ministry of Defense.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Dural arteriovenous fistulas (DAVFs) with cortical venous drainage (CVD) carry significant risks of cerebral ischemia and intracranial hemorrhage. Endovascular treatment (EVT) using Onyx, a copolymer‐based liquid embolic material, has become the preferred approach. However, the optimal treatment strategy for anterior cranial fossa DAVFs remains debated.

Methods

This retrospective study analyzed outcomes of EVT for DAVFs in a single center from 2002 to 2023. Patient data including demographics, clinical status, angiographic findings, embolization techniques, and outcomes were recorded. The results of the anterior fossa malformations were analyzed separately afterward.

Results

A total of 195 DAVFs were included in the study. The most common presenting symptom was hemorrhage (41%), most fistulas were located in the transverse and sigmoid sinus region (48%), and the majority of DAVFs had direct CVD (78%). Transarterial embolization with Onyx was the preferred treatment strategy in majority of cases (92%). Overall, 94% of patients showed improvement or stability on the modified Rankin Scale. Two patients died due to rebleeding after partial DAVF embolization. Onyx demonstrated higher immediate complete occlusion rate compared to other embolic materials (88% vs. 35%). Overall, 91% of fistulas were closed at the last follow‐up. Ten anterior fossa DAVFs were treated, resulting in clinical improvement and complete occlusion in all cases.

Conclusion

Based on the results of our study, we believe that a cure of DAVFs, including those in the anterior fossa, can be achieved in more than 90% of cases through transarterial Onyx embolization, given long‐term clinical experience.

Subjects

MeSH terms (MEDLINE)

Central Nervous System Vascular MalformationsEmbolization, TherapeuticFistulaHumansTreatment OutcomeRetrospective StudiesPolyvinyls

Author keywords

Onyxdural arteriovenous fistulasendovascular treatmenttransarterial embolization

Substances

Polyvinyls

Authors and institutions

  • Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Military University Hospital, Prague, Czech Republic.
  • Department of Radiology, Military University Hospital, Prague, Czech Republic.

ORCID profiles: Richard Voldřich

Funding

  • Agentura Pro Zdravotnický Výzkum České Republiky
  • Ministry of Defense

Cite

APA

Voldřich, R., Charvát, F., & Netuka, D. (2023). Copolymer liquid embolization of dural arteriovenous fistulas: A 20‐year single‐center experience. Journal of Neuroimaging, 33(6), 926-932. https://doi.org/10.1111/jon.13148

Vancouver

Voldřich R, Charvát F, Netuka D. Copolymer liquid embolization of dural arteriovenous fistulas: A 20‐year single‐center experience. Journal of Neuroimaging. 2023;33(6):926-932. doi:10.1111/jon.13148

BibTeX
@article{Voldich2023,
  author = {Voldřich, Richard and Charvát, František and Netuka, David},
  title = {Copolymer liquid embolization of dural arteriovenous fistulas: A 20‐year single‐center experience},
  journal = {Journal of Neuroimaging},
  year = {2023},
  volume = {33},
  number = {6},
  pages = {926--932},
  doi = {10.1111/jon.13148}
}
Start for free →